Enhancing Clinical Practice: Key Insights from the Intersection of Cardiac Imaging and Procedural Planning
Circle Cardiovascular Imaging partners with inHEART to distribute AI-driven digital twin of the heart for advanced cardiac procedural planning in the electrophysiology lab!
On May 16, 2024, Circle Cardiovascular Imaging Inc. and inHEART Inc. announced a global distribution agreement enabling Circle Cardiovascular Imaging to promote and market inHEART’s?advanced, artificial intelligence (AI)-enabled digital twin of the heart through its worldwide sales network. ?
Alongside Circle’s market-leading MR and CT capabilities for coronaries, heart failure, and structural heart, this partnership empowers cardiovascular professionals with the tools and insights they need to deliver high-quality patient care while optimizing practice performance.?More info here.
Did you know? Circle is the exclusive provider of WATCHMAN? TruPlan?, the leading procedural planning software for Left Atrial Appendage Closure (LAAC).
With TruPlan, you can swiftly and accurately evaluate LAA morphology and size, assess for thrombus, and develop a customized LAAC plan tailored to each patient's unique anatomy for your WATCHMAN? procedures. TruPlan offers innovative tools and features designed to enhance clinical guidance and ensure optimal outcomes. Plan your transseptal access with confidence and visualize the procedure with simulated Fluoro, TEE, and ICE views.?
Interested in learning more about TruPlan? Request a demo here!?
SCCT is around the corner!
We are excited to announce our participation in the SCCT conference in Washington, DC, and we look forward to meeting you there! If you're interested in learning about the latest features of cvi42 v6.1 or simply want to chat with us, you can book a demo in advance here.?
Stay tuned for updates on our activities at SCCT! ?
Did you miss our latest webinar in collaboration with SCCT?
Review it now here.
Title: Advantages of a single imaging software platform for your entire cardiac service line
Learning Objectives:
Speakers: Dr. Tim Fairbairn, Dr. Mike Morris, Dr. Tim Albert
Did you know? cvi42 v6.1 includes the latest updates in CAD-RADS 2.0
The Coronary Artery Disease Reporting and Data System (CAD-RADS) was initially created in 2016 to help standardize reporting for patients undergoing coronary CTA, and to guide next steps in patient management. CAD-RADS 2.0 was updated recently with an additional classifiers to grade plaque burden and ischemia additional to the stenosis grading. cvi42 v6.1 includes the latest updates in CAD-RADS 2.0, which allow physicians to easily apply CAD-RADS scoring to their cardiac CT reports. See the guidelines for more information on how to apply CAD-RADS to your cardiac CT reads.
Unveiling Heart Risks: Key Insights on CMD and Diastolic Dysfunction in INOCA Patients
A recent study explored the connection between coronary microvascular dysfunction (CMD) and left ventricular (LV) diastolic function in INOCA patients. Key findings include:?
These insights underscore the importance of assessing diastolic dysfunction in managing CMD.? Kong H, Cao J, Tian J, et al. Relationship between coronary microvascular dysfunction (CMD) and left ventricular diastolic function in patients with symptoms of myocardial ischemia with non-obstructive coronary artery disease (INOCA) by cardiovascular magnetic resonance feature-tracking. Clin Radiol. 2024;79(7):536-543. doi:10.1016/j.crad.2024.02.007
领英推荐
Assessing LV Function in Non-Compaction: MRI Study Insights
This recently published study explored how including or excluding trabeculations affects left ventricular (LV) function measurements in patients with left ventricular non-compaction (LVNC). Using cvi42, LV volume, mass, and ejection fraction (LVEF) were assessed in 30 LVNC patients and 16 controls. The results showed that excluding trabeculations resulted in normal LVEF in both groups, while including trabeculations increased LVEF by 9.8% in LVNC patients but decreased it by 10.9% in controls. These findings indicate that trabeculation inclusion significantly alters LVEF measurements, providing valuable insights for diagnosing LVNC.?
New HCM Guideline Published
The 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy (HCM) has been published. It offers critical updates and incorporates new evidence for healthcare professionals managing HCM patients. Review the Guideline here. ?
Ommen, S, Ho, C. et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024 Jun, 83 (23) 2324–2405. https://doi.org/10.1016/j.jacc.2024.02.014
Join the next ESCR webinar: Quantification in cardiovascular MRI: When and how to use it?
5 June 2024, 6pm CET
Register here.
Speakers:
?Moderator:?Nicola Galea, Rome/IT?
Interested in meeting us? Find us at:
Want to join an interactive case review session? Here are the coming courses and workshops that we support:
Interested in learning more about cvi42?
Contact us to get a 42-day trial of our solutions.
? 2024 Circle Cardiovascular Imaging Inc. All rights reserved.
Disclaimer: Not all modules or features are available in every region. Contact your local Circle representative for all regional availability.
Our emailing address is: [email protected]